# Creative Medical (CELZ) — News

CELZ · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/celz/news

## Recent headlines

- [Creative Medical Technology - Patent application expands IP protection for Ultrasome platform](https://www.ainvest.com/news/creative-medical-technology-patent-application-expands-ip-protection-ultrasome-platform-2609) — AInvest Wire, Sep 17, 2026
  Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for a patent application titled “Suppression of Diabetes Using Exosomes” (U.S. Application No. 17/931,868). Once issued, the patent will expand the…
- [Creative Medical Technology - Files new U.S. provisional patent application](https://www.ainvest.com/news/creative-medical-technology-files-provisional-patent-application-2609) — AInvest Wire, Sep 17, 2026
  Creative Medical Technology has recently filed a new U.S. provisional patent application, marking a strategic step in its intellectual property development. While specific details of the application remain confidential, the move aligns with broader industry trends emphasizing robust IP strategies .…
- [Creative Medical Technology - patent to extend IP protection for MyelocelZ platform in type 1 diabetes](https://www.ainvest.com/news/creative-medical-technology-patent-extend-ip-protection-myelocelz-platform-type-1-diabetes-2608) — AInvest Wire, Aug 6, 2026
  Creative Medical Technology Holdings, Inc. (CELZ) has announced a development related to its intellectual property (IP) portfolio, specifically for its MyelocelZ platform, which is being explored for the treatment of type 1 diabetes. The company has taken steps to extend IP protection for this…
- [Creative Medical Technology - receives USPTO notice of allowance for exosome-based Type 1 diabetes patent](https://www.ainvest.com/news/creative-medical-technology-receives-uspto-notice-allowance-exosome-based-type-1-diabetes-patent-2608) — AInvest Wire, Aug 6, 2026
- [Creative Medical Technology Holdings announces agreements for exercise of warrants for $4.5 million gross proceeds](https://www.ainvest.com/news/creative-medical-technology-holdings-announces-agreements-exercise-warrants-4-5-million-gross-proceeds-2607) — AInvest Wire, Jun 30, 2026
  Creative Medical Technology Holdings, Inc. (Nasdaq: CELZ) has announced agreements with certain holders of its existing warrants for the immediate exercise of outstanding warrants to raise approximately $4.2 million in gross proceeds. The transaction involves the exercise of warrants to purchase up…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).
